{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:58:56Z","timestamp":1793465936457,"version":"4.5.0"},"reference-count":27,"publisher":"Japan Atherosclerosis Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.5551\/jat.66185","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:09:13Z","timestamp":1777673353000},"page":"1049-1059","source":"Crossref","is-referenced-by-count":7,"title":["Lipoprotein(a) Distribution and Cardiovascular Risk in Japan: Insights from a Multi-center LEAP Study"],"prefix":"10.5551","volume":"33","author":[{"given":"Tomoaki","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Insured Medical Care Management, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsune","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Technology, Juntendo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Funabashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyorin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Jikei University Kashiwa Hospital"},{"name":"Department of General Medicine, The Jikei University Kashiwa Hospital"},{"name":"Section of Internal Medicine of Metabolism and Nutrition, The Jikei University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Hiraishi","sequence":"additional","affiliation":[{"name":"Department of Diabetology, Noda Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takae","family":"Ebihara","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Hadano","sequence":"additional","affiliation":[{"name":"Section of Internal Medicine of Metabolism and Nutrition, The Jikei University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Jikei University Kashiwa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Takeji","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Fukatsu","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Metabolism in Cardiovascular Disease, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Egawa","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Metabolism in Cardiovascular Disease, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Michikura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Shishikura","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketoshi","family":"Maehara","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Insured Medical Care Management, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Shiba-Harada","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Bioethics, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokg\u00f6zo\u011flu LS, Catapano AL. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J, 2022; 43: 3925-3946","DOI":"10.1093\/eurheartj\/ehac361"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J. Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality. JAMA, 2009; 302: 412","DOI":"10.1001\/jama.2009.1063"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol, 2022; 42","DOI":"10.1161\/ATV.0000000000000147"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kamstrup PR. Lipoprotein(a) and Cardiovascular Disease. Clin Chem, 2021; 67: 154-166","DOI":"10.1093\/clinchem\/hvaa247"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Duarte Lau F, Giugliano RP. Lipoprotein(a) and its Significance in Cardiovascular Disease. JAMA Cardiol, 2022; 7: 760","DOI":"10.1001\/jamacardio.2022.0987"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sahebkar A, Simental-Mend\u00eda LE, Pirro M, Banach M, Watts GF, Sirtori C, Al-Rasadi K, Atkin SL. Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials. Sci Rep, 2018; 8: 17887","DOI":"10.1038\/s41598-018-36204-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lampsas S, Xenou M, Oikonomou E, Pantelidis P, Lysandrou A, Sarantos S, Goliopoulou A, Kalogeras K, Tsigkou V, Kalpis A, Paschou SA, Theofilis P, Vavuranakis M, Tousoulis D, Siasos G. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. Molecules, 2023; 28: 969","DOI":"10.3390\/molecules28030969"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ying Q, Chan DC, Pang J, Marcovina SM, Barrett PHR, Watts GF. PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin\u2010treated patients with very high apolipoprotein(a) concentration. J Intern Med, 2022; 291: 870-876","DOI":"10.1111\/joim.13457"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Raal FJ, Giugliano RP, Sabatine MS, Koren MJ, Blom D, Seidah NG, Honarpour N, Lira A, Xue A, Chiruvolu P, Jackson S, Di M, Peach M, Somaratne R, Wasserman SM, Scott R, Stein EA. PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor\u2019s role. J Lipid Res, 2016; 57: 1086-1096","DOI":"10.1194\/jlr.P065334"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tsimikas S, Gordts PLSM, Nora C, Yeang C, Witztum JL. Statin therapy increases lipoprotein(a) levels. Eur Heart J, 2020; 41: 2275-2284","DOI":"10.1093\/eurheartj\/ehz310"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, Santos RD, Thanassoulis G, Witztum JL, Danthi S, Olive M, Liu L. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. J Am Coll Cardiol, 2018; 71: 177-192","DOI":"10.1016\/j.jacc.2017.11.014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Wilson DP, Jacobson TA, Jones PH, Koschinsky ML, McNeal CJ, Nordestgaard BG, Orringer CE. Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol, 2019; 13: 374-392","DOI":"10.1016\/j.jacl.2019.04.010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nago N, Kayaba K, Hiraoka J, Matsuo H, Goto T, Kario K, Tsutsumi A, Nakamura Y, Igarashi M. Lipoprotein(a) Levels in the Japanese Population: Influence of Age and Sex, and Relation to Atherosclerotic Risk Factors: The Jichi Medical School Cohort Study. Am J Epidemiol, 1995; 141: 815-821","DOI":"10.1093\/oxfordjournals.aje.a117516"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fujii E, Ako J, Takahashi Y, Toda M, Iekushi K, Yamashita S. Serum Lipoprotein(a) Levels and Their Association with Atherosclerotic Cardiovascular Disease in Japan. J Atheroscler Thromb, 2025; 32: 421-438","DOI":"10.5551\/jat.64953"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kim BJ, Lee MY, Choi H-I, Kwon M-J, Kang J-G. Lipoprotein(a)-related cardiovascular and all-cause mortalities in Korean adults. Eur J Prev Cardiol, 2023; 30: 308-317","DOI":"10.1093\/eurjpc\/zwac271"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yang P, Tang L, Guo H, He Y, Qin Y, Yan L, Li Z, Guo Y, Wang J. Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China. J Atheroscler Thromb, 2025; 32: 513-524","DOI":"10.5551\/jat.65214"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yoshida H, Kroes M, Sakai Y, Takahashi Y, Yamanaka Y, Crawford B, Ako J. Lipoprotein(a) in Japanese Patients With Cardiovascular Disease. JACC: Asia, 2025; 5: 1525-1539","DOI":"10.1016\/j.jacasi.2025.08.017"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Miida T, Hirayama S, Fukushima Y, Hori A, Ito S, Hinata M, Wakita M, Tabata H, Tamura Y, Watada H, Kawamori R, Vesper HW, Cobbaert CM. Harmonization of Lipoprotein(a) Immunoassays Using A Serum Panel Value Assigned with The IFCC-Endorsed Mass Spectrometry-Based Reference Measurement Procedure as A First Step Towards Apolipoprotein Standardization. J Atheroscler Thromb, 2025; 32: 580-595","DOI":"10.5551\/jat.65238"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Harada-Shiba M, Arai H, Ohmura H, Okazaki H, Sugiyama D, Tada H, Dobashi K, Matsuki K, Minamino T, Yamashita S, Yokote K. Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022. J Atheroscler Thromb, 2023; 30: 558-586","DOI":"10.5551\/jat.CR005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol, 2019; 73: e285-350","DOI":"10.1016\/j.jacc.2018.11.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Mu\u00f1oz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol, 2019; 74: e177-232","DOI":"10.1016\/j.jacc.2019.03.010"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lee S-R, Prasad A, Choi Y-S, Xing C, Clopton P, Witztum JL, Tsimikas S. LPA Gene, Ethnicity, and Cardiovascular Events. Circulation, 2017; 135: 251-263","DOI":"10.1161\/CIRCULATIONAHA.116.024611"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S, Khera A V. Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease. Arterioscler Thromb Vasc Biol, 2021; 41: 465-474","DOI":"10.1161\/ATVBAHA.120.315291"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Alonso R, Andres E, Mata N, Fuentes-Jim\u00e9nez F, Badim\u00f3n L, L\u00f3pez-Miranda J, Padr\u00f3 T, Mu\u00f1iz O, D\u00edaz-D\u00edaz JL, Mauri M, Ordov\u00e1s JM, Mata P. Lipoprotein(a) Levels in Familial Hypercholesterolemia. J Am Coll Cardiol, 2014; 63: 1982-1989","DOI":"10.1016\/j.jacc.2014.01.063"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE, Ridker PM. Lipoprotein(a) and Risk of Type 2 Diabetes. Clin Chem, 2010; 56: 1252-1260","DOI":"10.1373\/clinchem.2010.146779"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) O\u2019Donoghue ML, Fazio S, Giugliano RP, Stroes ESG, Kanevsky E, Gouni-Berthold I, Im K, Lira Pineda A, Wasserman SM, \u010ce\u0161ka R, Ezhov M V., Jukema JW, Jensen HK, Tokg\u00f6zo\u011flu SL, Mach F, Huber K, Sever PS, Keech AC, Pedersen TR, Sabatine MS. Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk. Circulation, 2019; 139: 1483-1492","DOI":"10.1161\/CIRCULATIONAHA.118.037184"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/8\/33_66185\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:49:10Z","timestamp":1785559750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/8\/33_66185\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.66185","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"article-number":"66185"}}